Added Value of 99m Tc-Octreotide Scintigraphy and 18 F-FDG-PET/CT in Clinical Prognosis of Neuroendocrine Tumors (NET)

Adela Cánoves Llombart,Irene Casans-Tormo,Héctor Rodríguez Parra,Jorge Sabater Sancho,Ahmed Amr-Rey,Viviana Carrero-Vásquez,Mari Carmen Redal-Peña

Added Value of 99m Tc-Octreotide Scintigraphy and 18 F-FDG-PET/CT in Clinical Prognosis of Neuroendocrine Tumors (NET)

2019

Adela Cánoves Llombart
Irene Casans-Tormo
Héctor Rodríguez Parra
Jorge Sabater Sancho
Ahmed Amr-Rey
Viviana Carrero-Vásquez
Mari Carmen Redal-Peña

Poster: "EANM 19 / EP-0357 / Added Value of 99mTc-Octreotide Scintigraphy and 18F-FDG-PET/CT in Clinical Prognosis of Neuroendocrine Tumors (NET)" by: "A. S. Canoves-Llombart, I. Casans-Tormo, H. Rodriguez-Parra, J. SABATER-SANCHO, A. AMR-REY, V. A. Carrero-Vasquez, M. C. Redal-Pena; Nuclear Medicine, University Clinic Hospital, Valencia, SPAIN"

Keywords:

Scintigraphy
Nuclear medicine
fdg pet ct
octreotide scintigraphy
clinical prognosis
Neuroendocrine tumors
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations